Cannabidiol Combination Compositions
AssigneeCompanion Sciences. LLC
InventorsGolan VAKNIN, Tami Bar
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention are directed to formulations comprising Cannabidiol (CBD) and glucosamine (Gln). Further embodiments of the invention are directed to methods of treating or preventing Arthritis, Osteoarthritis, Rheumatoid arthritis, Osteoporosis, Osteopenia, jaw pain, joint pain, knee pain, back pain, multiple sclerosis, Osteomalacia and Paget's disease of bone, wherein the method comprises administering a formulation comprising Cannabidiol (CBD) and glucosamine (Gln).
Claims24
A composition comprising Cannabidiol (CBD) and Glucosamine, and/or a pharmaceutically acceptable glucosamine salt, in a pharmaceutically acceptable dosage form.
-11. (canceled)
(canceled)
A method of treating a disease, condition, symptom or disorder associated with bone and joint diseases in a subject in need thereof;
- said method comprising administration of a therapeutically effective amount of a composition comprising Cannabidiol (CBD) and Glucosamine and/or a pharmaceutically acceptable glucosamine salt, in a pharmaceutically acceptable dosage form.
17-18. (canceled)
A method of increasing bioavailability of glucosamine in a therapeutic formulation containing an effective amount of glucosamine for treatment of at least one disease, condition, symptom or disorder associated with bone and joint diseases, the method comprising administering Cannabidiol (CBD) in the formulation in a predetermine ratio with the glucosamine.
28-30. (canceled)
Dependencies are inferred from the claim text.